States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
The new site enables end-to-end production of viral vector gene therapies
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
The lab will facilitate the development of herbal and natural-based solutions
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Subscribe To Our Newsletter & Stay Updated
